CH
ChitogenX Inc.
CHNXF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $878.1K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
32.5% upside
Current Price
$0.0076
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHNXF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 46.55%
ROA 403.64%
Debt
0 /100
High Int. coverage -1.57x
Current ratio 0.01x
Debt/Assets N/A
Stability
35 /100
Moderate Profitable years 0
Beta -2.09x
EPS volatility 49.00%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHNXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Pierre Laurin
Employees
5
Headquarters
Kirkland
Upcoming events
21 SEP
Earnings
Upcoming earnings report
28 SEP
Earnings
Upcoming earnings report